COR Cencora Inc

  1. Stocks
  2. Healthcare
  3. NYSE: COR

Price (delayed)

$318.04

Market cap

$60.69B

P/E Ratio

23.52

Dividend/share

$2.4

EPS

$13.52

Enterprise value

$69.6B

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 42
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 64

AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to ...

Highlights
The company's net income rose by 38% YoY and by 3% QoQ
COR's EPS is up by 38% year-on-year and by 3% since the previous quarter
The equity has soared by 54% YoY but it has decreased by 10% from the previous quarter
The company's debt rose by 42% YoY but it fell by 5% QoQ
The company's quick ratio fell by 4% YoY
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.amerisourcebergen.com
Peers: EQIX OLP STWD ALX

Key stats

What are the main financial stats of COR

COR stock price

How has the Cencora stock price performed over time
Intraday
1.06%
1 week
1.34%
1 month
4.94%
1 year
4.88%
YTD
-5.84%
QTD
12.39%

Financial performance

How have Cencora's revenue and profit performed over time
Revenue
$332.77B
Gross profit
$13.22B
Operating income
$3.04B
Net income
$2.62B
Gross margin
4%
Net margin
0.8%
The company's net income rose by 38% YoY and by 3% QoQ
The company's net margin rose by 33% YoY
COR's gross profit is up by 20% year-on-year and by 6% since the previous quarter
The company's gross margin rose by 14% YoY and by 5% QoQ

Price vs fundamentals

How does COR's price correlate with its fundamentals

Growth

What is Cencora's growth rate over time

Valuation

What is Cencora stock price valuation
COR P/E details
P/E
23.52
P/B
20.28
P/S
0.18
EV/EBIT
17.3
EV/EBITDA
15.17
EV/Sales
0.21
COR's EPS is up by 38% year-on-year and by 3% since the previous quarter
COR's P/E is 24% below its last 4 quarters average of 31.0 and 4% below its 5-year quarterly average of 24.5
The price to book (P/B) is 71% lower than the 5-year quarterly average of 69.4 and 27% lower than the last 4 quarters average of 27.6
The equity has soared by 54% YoY but it has decreased by 10% from the previous quarter
The P/S is 10% below the 5-year quarterly average of 0.2 and 10% below the last 4 quarters average of 0.2
Cencora's revenue has increased by 5% YoY

Efficiency

How efficient is Cencora business performance
The ROE has declined by 46% year-on-year and by 8% since the previous quarter
COR's return on sales is up by 33% year-on-year
The company's return on assets rose by 22% YoY
Cencora's ROIC has decreased by 18% YoY and by 6% from the previous quarter

Dividends

What is COR's dividend history
Dividend details
DPS
$2.4
Dividend yield
0.75%
Payout ratio
17.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Cencora financials performed over time
COR's total assets is 4% greater than its total liabilities
COR's total assets is up by 13% year-on-year and by 2.6% since the previous quarter
Cencora's total liabilities has increased by 12% YoY and by 3.2% from the previous quarter
The equity has soared by 54% YoY but it has decreased by 10% from the previous quarter
The company's debt rose by 42% YoY but it fell by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.